Skip to main content
. Author manuscript; available in PMC: 2008 Jun 18.
Published in final edited form as: J Immunol. 2001 Dec 1;167(11):6356–6365. doi: 10.4049/jimmunol.167.11.6356

FIGURE 3.

FIGURE 3

IL-2 transductants maintained their viability in the absence of exogenous IL-2 upon second restimulation with anti-CD3 and anti-CD28. Replicates of IL-2 transductants from the no IL-2 condition from a replica plate as shown in Fig. 2e, and YFP transductants and untransduced PBMC from +IL-2 condition from a replica plate as shown in Fig. 2f were subjected to the same experiment as described in the legend to Fig. 2. a and b, Photographs of cell clusters taken on day 5; and c and d, values of calculated viable cell equivalents.